Back to Search

KNSA

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
Data: 2026-08-03
$73.41
Price
-1.25%
Change
$82.94
52W High
$30.04
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Quick Stats
Aug 03, 2026

57.5

AI Score

HOLD

0.78

Volume Ratio

Oct 27, 2026

Next Earnings

15

+ve Days (30d)

15

-ve Days (30d)

KNSA Stock Summary

Last updated Aug 03, 2026

KNSA is currently trading at $73.41, positioned above its 200-day moving average of $48.16, indicating a long-term uptrend. The stock has a 52-week range of $30.04 to $82.94.

Technical Analysis: The 50-day moving average stands at $59.19, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 62.611, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.103, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates KNSA at 57.5/100 with a HOLD recommendation.

KNSA (Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares) Indicators

Last updated Aug 03, 2026

Indicator Value
RSI(14) 62.611
CMF (20) 0.103
ROC (10) 17.306
ADX (14) 42.075
Indicator Value
MACD (12,26,9) 4.354
AROONOSC (14) 57.143
WILLAMS %R (14) -41.661
MFI (14) 66.159
KNSA Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

KNSA Price vs Max Options Open Interest
KNSA Max Change In Options Open Interest

KNSA Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

KNSA Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

KNSA Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

KNSA Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares is above both the 50 Day and 200 Day SMA which is considered Bullish.

KNSA Moving Averages Analysis

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 03, 2026

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 03, 2026

KNSA (Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares) Simple Moving Averages

Moving Averages are last updated Aug 03, 2026

Days MA
10 70.17
20 66.74
30 64.77
50 59.19
100 54.33
200 48.16

KNSA Fundamental Analysis

P/E (Forward) 75.7576
P/E (Trailing) 82.3158
Market Cap ($) 6.1 billion
Earnings/Share ($) 0.95
Net Profit Margin (%) 0.0959
Dividend/Share ($) --
EPS Estimate Current Year ($) 1.1333
EPS Estimate Next Year ($) 1.5233
WallStreet Target Price ($) 98.00
Most Recent Quarter